ask="1.200"
ask_size="800"
average_daily_volume="236746"
bid="1.090"
bid_size="1000"
book_value="0.684"
change="-0.055"
change_from_200_day_moving_average="0.135"
change_from_50_day_moving_average="0.150"
change_from_52_week_high="-0.295"
change_From_52_week_low="0.415"
change_in_percent="-4.661%"
close="1.125"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.273"
ebitda="-15.76M"
eps_estimate_current_year="-0.290"
eps_estimate_next_quarter="-0.010"
eps_estimate_next_year="-0.110"
ex_dividend_date="N/A"
float_shares="44504000"
high="1.190"
high_52_weeks="1.420"
last_trade_date="2/14/2017"
last_trade_price="1.125"
last_trade_size="300"
last_trade_time="3:58pm"
low="1.060"
low_52_weeks="0.710"
market_capitalization="63.49M"
moving_average_200_day="0.990"
moving_average_50_day="0.975"
name="BioLineRx Ltd."
notes="N/A"
one_year_target_price="2.000"
open="1.190"
pe_ratio="N/A"
peg_ratio="0.000"
percent_change_from_200_day_moving_average="+13.594%"
percent_change_from_50_day_moving_average="+15.438%"
percent_change_from_52_week_high="-20.775%"
percent_change_from_52_week_low="+58.451%"
previous_close="1.180"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.725"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="56432000"
short_ratio="0.450"
stock_exchange="NCM"
symbol="BLRX"
volume="820059"
weeks_range_52="0.710 - 1.420"
